The Global AMR R&D Hub would like to thank all participants that either attended or presented at our virtual conference held on 2 December 2020. The recordings of all three conference sessions are now available as is the conference report that highlights the recommendations arising from the discussions. Please click here
15.12.2020: In collaboration with the EU Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI), the Global AMR R&D Hub publishes a policy brief “Incentivizing antibiotic access and innovation”. The brief presents the overall results from in-depth interviews with 13 countries – including 3 x outside of the EU. Findings include general support for antibiotic incentives, with the majority of interviewed countries preferring incentives that will secure access to both old and new antibiotics. Countries want more information on suitable multinational models and costs. Full manuscript is expected in 2021. Read the policy brief here.
19.11.2020: As of today the Dynamic Dashboard shows data on the close to 1900 organisations from 64 countries across the world that receive funding for AMR R&D. This new expansion of the functionalities allows a detailed look at the global fabric of AMR R&D. Several existing reports in the Dynamic Dashboard now allow filtering by the type of research organisation. Access the report at: https://dashboard.globalamrhub.org/reports/investments/research-organisations
18.11.2020: The Global AMR R&D Hub publishes its first report “The state of public and philanthropic investments in AMR R&D – The 2020 annual report of the Global AMR R&D Hub’s Dynamic Dashboard”. Based on the report the Board of Members has issued recommendations to the Group of 20.
The report represents the first consolidation of national AMR-related R&D funding and a start to providing a comprehensive global picture.
We are happy to invite you to our virtual conference “Translating AMR R&D mapping into policy and action” on 2 December 2020. For more details and to register please enter the event website here
On October 25, 2020 the Secretariat Lead of the Global AMR R&D Hub, Elmar Nimmesgern, participated in the panel discussion “Developing Antibiotics for children to achieve SDG 3” hosted by GARDP during this year’s World Health Summit. You can access his presentation here.
We kindly invite you to take part in a survey on the satisfaction with the Global AMR R&D Hub’s Dynamic Dashboard. This survey is conducted by the Public Policy and Management Institute (PPMI), an independent external evaluator of the Global AMR R&D Hub, with support from BIOCOM.
We would like to explore your satisfaction with the Dynamic Dashboard, including its user-friendliness, content and the overall quality. Your input would be very useful to the ongoing external evaluation of the Global AMR R&D Hub and its key deliverables. It should take, on average, around 5-10 minutes to complete all questions.
Please note that this is a voluntary survey. Our strict provisions ensure that your answers will remain confidential and shall be used only in aggregated form. For further information on our confidentiality policy, please see the Specific Privacy Statement here.
If you have any further questions about the survey, please contact Ms Sonata Brokevičiūtė at email@example.com.
We would be grateful if you could complete the survey by 29/09/2020.
Thank you in advance for your help!
Click Here to Start the Survey
The Global AMR R&D Hub is pleased to announce the launch of the Pipeline Gallery on the Dynamic Dashboard today. It brings together the information gathered and analysed by the WHO and The Pew Charitable Trusts and provides a high-level overview of antibacterial products in clinical development. More information can be found here
The Global AMR R&D Hub is pleased to announce the launch of the Incentives Gallery on the Dynamic Dashboard today. We are officially unveiling it during this week’s 4th Annual AMR Conference and we hope you can join us then!
Read our Newsletter Special Edition on Incentives
For any questions, suggestions, feedback or comments please email firstname.lastname@example.org
A special thanks to all the stakeholders who provided their input into the development and realisation of this piece.
Collaboration is essential to strengthen global research efforts and reduce duplication on priority infectious diseases relevant to antimicrobial resistance (AMR). We are pleased to partner with STAR-IDAZ and advance the knowledge about R&D investments in animal health related to AMR.